摘要
[目的]探讨立体定向铱192核素间质内放疗治疗高度恶性复发胶质瘤的疗效.[方法]对23例Ⅲ～Ⅳ期胶质瘤患者行铱192核素高剂量率间质内放疗.[结果]临床症状和体征消失5例,改善12例,无效或恶化5例.无严重并发症发生.1年生存率为11%,复发后平均生存期为6.2个月.[结论]立体定向铱192核素问质内放疗能延长病人的生存期及改善生存质量,安全有效,并发症少.
To ivestigate the preliminary results of stereotactic 192 Ir interstitial brachytherapy for re-current malignant gliomas.Stereotactic brachytherapy with iridium-192were performed in23pa-tients with gradeⅢ～Ⅳastrocytoma and glioblastoma.All clinical symptoms disappeared in5cases,improved in12cases,and no effect was found in5cases.No serious complications were observed.The l-year survival rate after brachytherapy was11%.The median survival after recurrence was6.2months.[Conclusion]The interstitial brachytherapy can prolong the survival and improve the quality of life,and is effective and safe for recurrent malignant gliomas.
出处
《中国肿瘤》
CAS
2003年第7期424-426,共3页
China Cancer
关键词
胶质瘤
间质内放疗
铱
gliomas
interstitial brachytherapy
iridium
